BIT 2.63% 3.7¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-21

  1. 971 Posts.
    lightbulb Created with Sketch. 300
    The answers you seek require more trials and more $$ and hell of a lot more time. Without a partner this is a never ending tin rattling escapade to keep MM living a luxurious life working from her holiday home and endless knitting. These trials should be delivering more convincing evidence by now.... all I am hearing is .... "while not demonstrating a rise in CD4 cells, are of interest and *may* portend clinical impact." We don't want may or might at this end of the road.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.001(2.63%)
Mkt cap ! $33.38M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $38.58K 1.029M

Buyers (Bids)

No. Vol. Price($)
2 511933 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 93887 2
View Market Depth
Last trade - 14.30pm 03/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.